News

Sunnyvale, CA - January 10th, 2005 Blueshift Biotechnologies, Inc. announced today an assay development collaboration with Active Motif of Carlsbad, California. The two companies are working together to convert existing and develop new assays to take… Read More
Sunnyvale, CA - January 3rd, 2005 Blueshift Biotechnologies, Inc. announced today the launch of its first product, the IsoCyteTM. The IsoCyteTM is a bench top fluorescence laser scanning imager with the unique ability to generate two-dimensional… Read More
Sunnyvale, Calif., October 25, 2004 - Molecular Devices Corporation (Nasdaq: MDCC), today announced the introduction of SpectraMax® M5, a five-mode multi-detection microplate reader system, and the latest addition to the company's popular SpectraMax… Read More
Sunnyvale, Calif., September 13, 2004 - Molecular Devices Corporation (Nasdaq: MDCC), today announced the introduction of its IMAP Substrate Finder for Tyrosine Kinases, following the release of its initial Substrate Finder for Serine/Threonine Kinases… Read More
Sunnyvale, Calif., July 1, 2004 - Molecular Devices Corporation (Nasdaq: MDCC), today announced that it has completed its acquisition of Axon Instruments, Inc. The stockholders of both companies have approved the transaction, and all regulatory… Read More
Sunnyvale, Calif., July 15, 2004 - Molecular Devices Corporation (Nasdaq: MDCC), today announced the first shipment of the SynchroMax ET Plate Handling Robot-the latest addition to its line of microplate readers and liquid handling systems. The… Read More
Sunnyvale, Calif., June 1, 2004 - Molecular Devices Corporation (Nasdaq: MDCC), today announced the introduction of FLIPRTETRA the first system that enables researchers to significantly increase throughput of cell-based assays by measuring 1536 kinetic… Read More
Molecular Devices Corporation opened its "Center of Excellence" in Downingtown, Pennsylvania on May 6, 2004. Located at the companies' Universal Imaging Corporation facility, the center features fully-equipped laboratories and training classrooms to… Read More
Sunnyvale, Calif., March 29, 2004 - Molecular Devices Corporation (Nasdaq: MDCC), a leader in innovative solutions for drug discovery and life sciences research, today announced the launch of the latest addition to its IMAP Platform, the IMAP Substrate… Read More
Sunnyvale, Calif., March 21, 2004 - Molecular Devices Corporation (Nasdaq: MDCC), today announced that it has entered into a definitive agreement to acquire Axon Instruments, Inc., (ASX:AXN.AX) for approximately U.S. $70 million in cash and approximately… Read More